Finance

Lists
RADX:NASDAQ
RADIOPHARM THERANOSTICS ADR
$2.08
-1.89%
(-0.040) 1D
$1.70
-18.27% (-0.38)
Pre-market
Closed: Sep 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RADX...
Open
$2.15
High
$2.47
Low
$2.05
Mkt. cap
35.13M
Avg. vol.
65.56K
Volume
354.00
52-wk high
$16.25
52-wk low
$2.04
Shares outstanding
14.46M
No. of employees
14
Open
$2.15
High
$2.47
Low
$2.05
Mkt. cap
35.13M
Avg. vol.
65.56K
Volume
354.00
52-wk high
$16.25
52-wk low
$2.04
Shares outstanding
14.46M
No. of employees
14
News stories
From web sources and news partners
About RADIOPHARM THERANOSTICS ADR
CEO-
Employees14
Founded2021
Headquarters-
SectorBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Initiated
$16.00
+669.2%
06/04/2026
Michael Okunewitch
Maxim Group
Buy
Maintained
$15.00
+621.2%
03/25/2026
Justin Walsh
JonesTrading
Buy
Reiterated
$30.00
+1,342.3%
03/25/2026
Yuan Zhi
B. Riley Securities
Buy
Maintained
$16.00
+669.2%
12/16/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.10M
3.10M
3.65M
3.65M
Cost of goods sold
11.30M
11.30M
-10.05M
-10.05M
Cost of revenue
11.30M
11.30M
-10.05M
-10.05M
Research and development expenses
-
-
22.35M
22.35M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.18M
4.18M
3.92M
3.92M
Operating expense
4.95M
4.95M
26.71M
26.71M
Total operating expenses
16.25M
16.25M
16.67M
16.67M
Operating income
-13.14M
-13.14M
-13.02M
-13.02M
Other non operating income
-
-
-434.08K
-434.08K
EBT including unusual items
-14.05M
-14.05M
-14.39M
-14.39M
EBT excluding unusual items
-13.37M
-13.37M
-13.28M
-13.28M
Income tax expense
67.15K
67.15K
-39.93K
-39.93K
Effective tax rate
-0.48%
-0.48%
0.28%
0.28%
Other operating expenses
-
-
-
-
Net income
-13.48M
-13.48M
-14.09M
-14.09M
Net profit margin
-434.67%
-434.67%
-386.15%
-386.15%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-32.55K
-32.55K
-23.64K
-23.64K
Net interest expenses
-32.55K
-32.55K
-23.64K
-23.64K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.47M
-12.47M
-12.34M
-12.34M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps